
Changavalli Venkat
About Changavalli Venkat
Data last updated:
Changavalli Venkat is a Director at Rubicon Research Limited (since 2024) and Director at Sree Ramachandra Health Services Private Limited (since 2023). The companies operate in Chemicals, Healthcare and Education. The 2 current companies with reported revenue have a combined latest revenue of ₹1,027 Cr; the largest is Rubicon Research Limited at ₹872 Cr (FY 2024). Earlier, Changavalli Venkat was a Director at Institute Of Insurance And Risk Management (2023–2024) and Director at Gene2go Private Limited (2023) and 6 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Jun 2024 | 1999 | ₹872 Cr (FY 2024) | Active | |
| Director | 22 Mar 2023 | 2011 | ₹155 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 Jan 2023 | 2002 | ₹12.93 Cr (FY 2023) | Active | |
| Director | 29 Mar 2023 | 2023 | Active | ||
| Director | 22 Jan 2014 | 2007 | ₹1.09 Cr (FY 2025) | Active | |
| Director | 20 Sep 2013 | 2010 | Active | ||
| Director | 17 Mar 2011 | 2007 | ₹34.38 Cr (FY 2025) | Active | |
| Managing Director | 27 Mar 2015 | 2014 | ₹196 Cr (FY 2023) | Active | |
| Director | 07 Jun 2017 | 2010 | ₹10.17 Cr (FY 2016) | Active | |
| Director | 03 Mar 2017 | 2017 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Changavalli Venkat
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Changavalli Venkat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Changavalli Venkat
Changavalli Venkat currently holds 2 directorships: Rubicon Research Limited (Director, since 11 Jun 2024, revenue ₹872 Cr (FY 2024)); Sree Ramachandra Health Services Private Limited (Director, since 22 Mar 2023, revenue ₹155 Cr (FY 2024)).
Changavalli Venkat was first appointed on 17 Mar 2011 as Director at Butterfly Edufields Private Limited. The most recent appointment on record is 11 Jun 2024 at Rubicon Research Limited.
The 2 current companies of Changavalli Venkat that report revenue have a combined latest revenue of ₹1,027 Cr: Rubicon Research Limited ₹872 Cr (FY 2024); Sree Ramachandra Health Services Private Limited ₹155 Cr (FY 2024).
Changavalli Venkat held 8 earlier board appointments: Institute Of Insurance And Risk Management (Director, 31 Jan 2023 to 23 Apr 2024); Gene2go Private Limited (Director, 29 Mar 2023 to 08 Dec 2023); Saath Livelihood Services (Director, 22 Jan 2014 to 25 Sep 2015); Embrace India (Director, 20 Sep 2013 to 13 Nov 2015); Butterfly Edufields Private Limited (Director, 17 Mar 2011 to 18 Jan 2021); and 3 more.
The current boards of Changavalli Venkat's companies include Deepashree Omkar Tanksale (Rubicon Research Limited), Kumarapuram Gopalakrishnan Ananthakrishnan (Rubicon Research Limited), Milind Anil Patil (Rubicon Research Limited), Nitin Jajodia (Rubicon Research Limited), Parag Suganchand Sancheti (Rubicon Research Limited), Parag Suganchand Sancheti (Rubicon Research Limited), among others.